The 160-acre plant in Nashik, Maharashtra, owned by technology supplier ABB India Limited, received a purchase order from Reliance Life Sciences (RLS) to automate control systems for their new biosimilars and plasma proteins manufacturing facilities.

The scope encompasses complete automation of the manufacturing process using ABB’s flagship Distributed Control System (DCS) Ability System 800xA, Remote I/O systems, Batch Recipe Management, and MES Integration," the company said in a release.

The System 800xA, which will be installed in a virtualized environment, interfaces seamlessly with various skid systems and is used extensively for seamless operator interaction, batch control, and production information on the factory floor, it added.

With automating the said solution, RLS will be able to attain operational excellence, reduce time to market, and ensure strict quality control of their manufacturing processes.